{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:40:12Z","timestamp":1793356812048,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2042777"],"award-info":[{"award-number":["APP2042777"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["2019\/TPG2165"],"award-info":[{"award-number":["2019\/TPG2165"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ctro.2026.101312","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:10:22Z","timestamp":1791475822000},"page":"101312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Study protocol for the TROG 21.08 VITaL trial: a randomized controlled trial investigating ventilation imaging to improve the quality of life for patients with lung cancer treated with radiation therapy"],"prefix":"10.1016","volume":"62","author":[{"given":"Shalini K.","family":"Vinod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashendra","family":"Senthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynleen","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasantha","family":"Jayamanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hardcastle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary L.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kipritidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Zwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guneet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal A.","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Mercieca-Bebber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan K.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Cavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surein","family":"Arulananda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Eikelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Silvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Keall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctro.2026.101312_bb0005","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101312_bb0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012","volume":"112","author":"Barton","year":"2014","journal-title":"Radiother. Oncol."},{"issue":"10","key":"10.1016\/j.ctro.2026.101312_bb0020","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1080\/0284186X.2019.1634835","article-title":"Patient-reported lung symptoms and quality of life before and after radiation therapy for non-small cell lung cancer: correlation with radiation pneumonitis and functional imaging","volume":"58","author":"Farr","year":"2019","journal-title":"Acta Oncol."},{"issue":"10","key":"10.1016\/j.ctro.2026.101312_bb0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clon.2023.07.003","article-title":"Pneumonitis after concurrent chemoradiation and immune checkpoint inhibition in patients with locally advanced non-small cell lung cancer","volume":"35","author":"Altan","year":"2023","journal-title":"Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ctro.2026.101312_bb0030","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.21037\/jtd-20-1792","article-title":"Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer","volume":"12","author":"Hassanzadeh","year":"2020","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.ctro.2026.101312_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-021-01930-2","article-title":"Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study","volume":"16","author":"Jang","year":"2021","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ctro.2026.101312_bb0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.lungcan.2021.08.019","article-title":"Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005\/CRIMSON)","volume":"161","author":"Saito","year":"2021","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.ctro.2026.101312_bb0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cllc.2021.01.017","article-title":"Incidence and risk factors of symptomatic radiation pneumonitis in non\u2013small-cell lung cancer patients treated with concurrent chemoradiotherapy and consolidation durvalumab","volume":"22","author":"Shintani","year":"2021","journal-title":"Clin Lung Cancer"},{"issue":"12","key":"10.1016\/j.ctro.2026.101312_bb0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctro.2026.101312_bb0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtho.2022.10.003","article-title":"Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from the PACIFIC-R study","volume":"18","author":"Girard","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctro.2026.101312_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.lungcan.2020.10.006","article-title":"Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): real-world data on survival and safety from the German expanded-access program (EAP)","volume":"150","author":"Faehling","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctro.2026.101312_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2022.10.002","article-title":"Treatment-related pulmonary adverse events induced by chemoradiation and durvalumab affect survival in locally advanced non-small cell lung cancer","volume":"176","author":"Xu","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101312_bb0070","doi-asserted-by":"crossref","unstructured":"Midroni J, Salunkhe R, Liu Z, Chow R, Boldt G, Palma D, Hoover D, Vinogradskiy Y, Raman S. Incorporation of Functional Lung Imaging Into Radiation Therapy Planning in Patients With Lung Cancer: A Systematic Review and Meta-Analysis. Int J Radiat Oncol Biol Phys. 2024 Oct 1;120(2):370-408. doi: 10.1016\/j.ijrobp.2024.04.001. Epub 2024 Apr 15. PMID: 38631538; PMCID: PMC11580018.","DOI":"10.1016\/j.ijrobp.2024.04.001"},{"issue":"3","key":"10.1016\/j.ctro.2026.101312_bb0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijrobp.2005.03.023","article-title":"Quantification of regional ventilation from treatment planning CT","volume":"62","author":"Guerrero","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ctro.2026.101312_bb0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.radonc.2018.07.014","article-title":"Functional lung imaging in radiation therapy for lung cancer: a systematic review and meta-analysis","volume":"129","author":"Bucknell","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"11","key":"10.1016\/j.ctro.2026.101312_bb0085","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.clon.2016.08.005","article-title":"Functional image-guided radiotherapy planning for normal lung avoidance","volume":"28","author":"Ireland","year":"2016","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ctro.2026.101312_bb0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2019.03.010","article-title":"Imaging of regional ventilation: is CT ventilation imaging the answer? A systematic review of the validation data","volume":"137","author":"Hegi-Johnson","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ctro.2026.101312_bb0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2017.04.024","article-title":"Evaluating the toxicity reduction with computed tomographic ventilation functional avoidance radiation therapy","volume":"99","author":"Faught","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2026.101312_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijrobp.2017.03.051","article-title":"Evaluating which dose-function metrics are most critical for functional-guided radiation therapy","volume":"99","author":"Faught","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.ctro.2026.101312_bb0105","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1118\/1.4960367","article-title":"Should regional ventilation function be considered during radiation treatment planning to prevent radiation-induced complications?","volume":"43","author":"Lan","year":"2016","journal-title":"Med. Phys."},{"issue":"4","key":"10.1016\/j.ctro.2026.101312_bb0110","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1118\/1.3358128","article-title":"Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging","volume":"37","author":"Munawar","year":"2010","journal-title":"Med. Phys."},{"issue":"3","key":"10.1016\/j.ctro.2026.101312_bb0115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ijrobp.2004.04.037","article-title":"Regional differences in lung radiosensitivity after radiotherapy for non\u2013small-cell lung cancer","volume":"60","author":"Seppenwoolde","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ctro.2026.101312_bb0120","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijrobp.2013.01.004","article-title":"Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes","volume":"86","author":"Vinogradskiy","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.ctro.2026.101312_bb0125","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2021.10.147","article-title":"Results of a multi-institutional phase 2 clinical trial for 4DCT-ventilation functional avoidance thoracic radiation therapy","volume":"112","author":"Vinogradskiy","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101312_bb0130","doi-asserted-by":"crossref","unstructured":"Baschnagel AM, Flakus MJ, Wallat EM, Wuschner AE, Chappell RJ, Bayliss RA, Kimple RJ, Christensen GE, Reinhardt JM, Bassetti MF, Bayouth JE. A Phase 2 Randomized Clinical Trial Evaluating 4-Dimensional Computed Tomography Ventilation-Based Functional Lung Avoidance Radiation Therapy for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2024 Aug 1;119(5):1393-1402. doi: 10.1016\/j.ijrobp.2024.02.019. Epub 2024 Feb 20. PMID: 38387810.","DOI":"10.1016\/j.ijrobp.2024.02.019"},{"key":"10.1016\/j.ctro.2026.101312_bb0135","doi-asserted-by":"crossref","unstructured":"Ito S, Nakajima Y, Fujita Y, Capaldi DPI, Sheikh K, Parraga G, Kabus S, Palma DA, Yaremko B, Hoover D, Yamamoto T. Comparison of Computed Tomography Ventilation Imaging and Hyperpolarized 3He Magnetic Resonance Imaging in Patients With Lung Cancer. Int J Radiat Oncol Biol Phys. 2026 Sep 1;126(1):220-229. doi: 10.1016\/j.ijrobp.2026.02.243. Epub 2026 Mar 7. PMID: 41802548.","DOI":"10.1016\/j.ijrobp.2026.02.243"},{"issue":"5","key":"10.1016\/j.ctro.2026.101312_bb0140","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.ijrobp.2022.11.026","article-title":"Four-dimensional computed tomography ventilation image guided lung functional avoidance radiation therapy: a single-arm prospective pilot clinical trial","volume":"115","author":"Yamamoto","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101312_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109553","article-title":"Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients","volume":"182","author":"Flakus","year":"2023","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101312_bb0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.3969","article-title":"Quality of life analysis of a radiation dose\u2013escalation study of patients with non\u2013small-cell lung cancer: a secondary analysis of the radiation therapy oncology group 0617 randomized clinical trial","volume":"2","author":"Movsas","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101312_bb0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.lungcan.2022.06.003","article-title":"Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab","volume":"170","author":"Gao","year":"2022","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.ctro.2026.101312_bb0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.prro.2018.12.003","article-title":"Standardizing normal tissue contouring for radiation therapy treatment planning: an ASTRO consensus paper","volume":"9","author":"Wright","year":"2019","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101312_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-934","article-title":"Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial","volume":"14","author":"Hoover","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2026.101312_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110118","article-title":"Common sense (radiation) oncology: redefining targets in radiotherapy","volume":"193","author":"Sanford","year":"2024","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101312_bb0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0169-5002(95)00450-F","article-title":"Reliability and validity of the functional assessment of Cancer therapy\u2014lung (FACT-L) quality of life instrument","volume":"12","author":"Cella","year":"1995","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.ctro.2026.101312_bb0180","article-title":"An analysis of clinical toxic effects and quality of life as a function of radiation dose and volume after lung stereotactic body radiation therapy","volume":"6","author":"Devpura","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101312_bb0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0895-4356(01)00477-2","article-title":"What is a clinically meaningful change on the functional assessment of cancer therapy\u2013lung (FACT-L) questionnaire?: results from Eastern Cooperative Oncology Group (ECOG) study 5592","volume":"55","author":"Cella","year":"2002","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101312_bb0190","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/j.ijrobp.2022.07.1531","article-title":"Timing of radiation pneumonitis in stage 3 non-small cell lung cancer patients by receipt of durvalumab","volume":"114","author":"Mushonga","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.ctro.2026.101312_bb0195","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jval.2021.01.007","article-title":"The functional assessment of cancer therapy eight dimension (FACT-8D), a multi-attribute utility instrument derived from the cancer-specific FACT-general (FACT-G) quality of life questionnaire: development and Australian value set","volume":"24","author":"King","year":"2021","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.ctro.2026.101312_bb0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated health economic evaluation reporting standards (CHEERS)\u2014explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.ctro.2026.101312_bb0205","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijrobp.2022.04.047","article-title":"Functional lung avoidance for individualized radiation therapy: results of a double-masked, randomized controlled trial","volume":"113","author":"Yaremko","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2026.101312_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-021-01259-0","article-title":"Characteristics and patient-reported outcomes associated with dropout in severely affected oncological patients: an exploratory study","volume":"21","author":"Gebert","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"issue":"10","key":"10.1016\/j.ctro.2026.101312_bb0215","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/jnci\/djac128","article-title":"Listening to the patient voice adds value to cancer clinical trials","volume":"114","author":"Brundage","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"issue":"2\u20133","key":"10.1016\/j.ctro.2026.101312_bb0220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0169-5002(00)00179-3","article-title":"Quality of life in lung cancer patients: as an important prognostic factor","volume":"31","author":"Montazeri","year":"2001","journal-title":"Lung Cancer"},{"issue":"13","key":"10.1016\/j.ctro.2026.101312_bb0225","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1200\/JCO.2010.33.4631","article-title":"Relationship between deficits in overall quality of life and non\u2013small-cell lung cancer survival","volume":"30","author":"Sloan","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctro.2026.101312_bb0230","first-page":"3669","article-title":"The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review","volume":"24","author":"Atkinson","year":"2016","journal-title":"Support Care Cancer"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826002077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826002077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:03:33Z","timestamp":1793354613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826002077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":45,"alternative-id":["S2405630826002077"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101312","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study protocol for the TROG 21.08 VITaL trial: a randomized controlled trial investigating ventilation imaging to improve the quality of life for patients with lung cancer treated with radiation therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101312"}}